{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:36:45Z","timestamp":1793367405172,"version":"4.5.0"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX005678"],"award-info":[{"award-number":["I01BX005678"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54 GM115458"],"award-info":[{"award-number":["U54 GM115458"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bcp.2024.116634","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T06:08:54Z","timestamp":1731564534000},"page":"116634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"P3","title":["Role of Relaxin Signaling in Cancer: A Review"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4500-8546","authenticated-orcid":false,"given":"Anupam","family":"Kotwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney S.","family":"Goldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0755-6103","authenticated-orcid":false,"given":"Robert G.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116634_b0005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3181\/00379727-23-3107","article-title":"Experimental relaxation of the pubic ligament of the guinea pig","volume":"23","author":"Hisaw","year":"1926","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.bcp.2024.116634_b0010","doi-asserted-by":"crossref","unstructured":"Bathgate, R. A., Halls, M. L., van der Westhuizen, E. T., Callander, G. E., Kocan, M., andSummers, R. J. (2013) Relaxin family peptides and their receptors Physiological Reviews 93, 405-480 10.1152\/physrev.00001.2012; 10.1152\/physrev.00001.2012.","DOI":"10.1152\/physrev.00001.2012"},{"key":"10.1016\/j.bcp.2024.116634_b0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bjp.0707140","article-title":"Relaxin family peptide receptors - former orphans reunite with their parent ligands to activate multiple signalling pathways","volume":"150","author":"Halls","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116634_b0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mce.2019.02.001","article-title":"Emerging roles for the relaxin\/RXFP1 system in cancer therapy","volume":"487","author":"Thanasupawat","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116634_b0025","doi-asserted-by":"crossref","unstructured":"Jung, J., andHan, H. (2024) The diverse influences of relaxin-like peptide family on tumor progression: Potential opportunities and emerging challenges Heliyon 10, 10.1016\/j.heliyon.2024.e24463.","DOI":"10.1016\/j.heliyon.2024.e24463"},{"key":"10.1016\/j.bcp.2024.116634_b0030","first-page":"641","article-title":"A review of studies of breast cancer in human populations excluding endocrine studies","volume":"65","author":"Campbell","year":"1972","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.bcp.2024.116634_b0035","volume":"75","author":"Li","year":"2021","journal-title":"Parity and Risk of Developing Breast Cancer According to Tumor Subtype: A Systematic Review and Meta-Analysis Cancer Epidemiol"},{"key":"10.1016\/j.bcp.2024.116634_b0040","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/oxfordjournals.aje.a117079","article-title":"Reproductive Risk Factors in a Prospective Study of Breast Cancer: The Nurses' Health Study","volume":"139","author":"Rosner","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bcp.2024.116634_b0045","first-page":"209","article-title":"Age at first birth and breast cancer risk","volume":"43","author":"MacMahon","year":"1970","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.bcp.2024.116634_b0050","first-page":"991","article-title":"Mammary Carcinogenesis by 3-Methylcholanthrene. II. Inhibitory Effect of Pregnancy and Lactation on Tumor Induction2 JNCI","volume":"25","author":"Dao","year":"1960","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.bcp.2024.116634_b0055","first-page":"567","article-title":"Mammary Carcinogenesis by 3-Methylcholanthrene. I","volume":"23","author":"Dao","year":"1959","journal-title":"Hormonal Aspects in Tumor Induction and Growth JNCI: Journal of the National Cancer Institute"},{"key":"10.1016\/j.bcp.2024.116634_b0060","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/bjc.1965.19","article-title":"Effect of Pregnancy and Lactation on Growth of Mammary Tumours Induced by 7,12-Dimethylbenz(a)anthracene (DMBA)","volume":"19","author":"McCormick","year":"1965","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2024.116634_b0065","first-page":"50","volume":"6","author":"Cutts","year":"1966","journal-title":"Estrogen-Induced Breast Cancer in the Rat Proc Can Cancer Conf"},{"key":"10.1016\/j.bcp.2024.116634_b0070","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/bjc.1967.69","article-title":"The effect of relaxin upon DMBA-induced mammary cancer in female rats","volume":"21","author":"Plunkett","year":"1967","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2024.116634_b0075","first-page":"59","article-title":"Immuno-neutralization of circulating relaxin does not alter the breast cancer-protective action of parity in MNU-treated rats","volume":"4","author":"Steinetz","year":"2004","journal-title":"J Exp Ther Oncol"},{"key":"10.1016\/j.bcp.2024.116634_b0080","first-page":"2077","article-title":"andSepp\u00e4l\u00e4, M","volume":"52","author":"Yki-J\u00e4rvinen","year":"1983","journal-title":"Immunohistochemical Demonstration of Relaxin in Gynecologic Tumors Cancer"},{"key":"10.1016\/j.bcp.2024.116634_b0085","first-page":"381","article-title":"Serum Relaxin in Patients With Hydatidiform Mole","volume":"67","author":"Seki","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bcp.2024.116634_b0090","unstructured":"S. Bongers-Binder A. Burgardt H. Seeger W. Voelter T.H. Lippert Distribution of Immunoreactive Relaxin in the Genital Tract and in the Manmary Gland of Non-Pregnant Women CEOG 18 1991 161\u2013164 pii\/1634203078282-2083266612."},{"key":"10.1016\/j.bcp.2024.116634_b0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4161\/cbt.5.1.2289","article-title":"The role of relaxin in endometrial cancer","volume":"5","author":"Kamat","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.bcp.2024.116634_b0100","doi-asserted-by":"crossref","unstructured":"M. Fue Y. Miki K. Takagi C. Hashimoto N. Yaegashi T. Suzuki et al. Relaxin 2\/RXFP1 Signaling Induces Cell Invasion via the \u03b2-Catenin Pathway in Endometrial Cancer Int J Mol Sci 19, 2438 2018 https:\/\/www.mdpi.com\/1422-0067\/19\/8\/2438.","DOI":"10.3390\/ijms19082438"},{"key":"10.1016\/j.bcp.2024.116634_b0105","doi-asserted-by":"crossref","unstructured":"Burston, H. E., Kent, O. A., Communal, L., Udaskin, M. L., Sun, R. X., Brown, K. R. et al. (2021) Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancer The Journal of Clinical Investigation 131, 10.1172\/JCI142677.","DOI":"10.1172\/JCI142677"},{"key":"10.1016\/j.bcp.2024.116634_b0110","first-page":"1101","article-title":"Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer","volume":"35","author":"Sk\u00f6ld","year":"2024","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bcp.2024.116634_b0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1677\/joe.0.1400321","article-title":"Immunocytochemical identification of a relaxin-like protein in gastrointestinal epithelium and carcinoma: a preliminary report","volume":"140","author":"Stemmermann","year":"1994","journal-title":"J Endocrinol"},{"key":"10.1016\/j.bcp.2024.116634_b0120","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1002\/pmic.200401196","article-title":"Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis","volume":"5","author":"Alfonso","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.bcp.2024.116634_b0125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1677\/jme.0.0120351","article-title":"Human relaxins in normal, benign and neoplastic breast tissue","volume":"12","author":"Tashima","year":"1994","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116634_b0130","first-page":"298","article-title":"andBryant-Greenwood, G","volume":"335","author":"Mazoujian","year":"1990","journal-title":"Relaxin in Breast Tissue the Lancet"},{"key":"10.1016\/j.bcp.2024.116634_b0135","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1439-0531.2009.01385.x","article-title":"Investigation of the Local Expression of the Relaxin System in Canine Mammary Tumours","volume":"44","author":"Lamp","year":"2009","journal-title":"Reprod. Domest. Anim."},{"key":"10.1016\/j.bcp.2024.116634_b0140","first-page":"70","article-title":"andEinspanier, A","volume":"11","author":"Lamp","year":"2013","journal-title":"The Metastatic Potential of Canine Mammary Tumours Can Be Assessed by mRNA Expression Analysis of Connective Tissue Modulators Vet Comp Oncol"},{"key":"10.1016\/j.bcp.2024.116634_b0145","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1746-6148-9-138","article-title":"Five markers useful for the distinction of canine mammary malignancy","volume":"9","author":"Paw\u0142owski","year":"2013","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.bcp.2024.116634_b0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0303-7207(96)03770-7","article-title":"Expression of human relaxin genes: characterization of a novel alternatively-spliced human relaxin mRNA species","volume":"118","author":"Gunnersen","year":"1996","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bcp.2024.116634_b0155","doi-asserted-by":"crossref","unstructured":"Kietz, S., Feng, S., Agoulnik, A., andHombach-Klonisch, S. (2009) Estrogen and TCDD Influence RLN2 Gene Activity in Estrogen Receptor-Positive Human Breast Cancer Cells Annals of the New York Academy of Sciences 1160, 367-373 https:\/\/doi.org\/10.1111\/j.1749-6632.2009.03836.x.","DOI":"10.1111\/j.1749-6632.2009.03836.x"},{"key":"10.1016\/j.bcp.2024.116634_b0160","doi-asserted-by":"crossref","unstructured":"Figueiredo, K. A., Palmer, J. B., Mui, A. L., Nelson, C. C., andCox, M. E. (2005) Demonstration of upregulated H2 relaxin mRNA expression during neuroendocrine differentiation of LNCaP prostate cancer cells and production of biologically active mammalian recombinant 6 histidine-tagged H2 relaxin Ann N Y Acad Sci 1041, 320-327, http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15956728.","DOI":"10.1196\/annals.1282.051"},{"key":"10.1016\/j.bcp.2024.116634_b0165","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/pros.20423","article-title":"Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens","volume":"66","author":"Thompson","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.bcp.2024.116634_b0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1677\/jme.0.0150153","article-title":"Characterization of human relaxin gene regulation in the relaxin-expressing human prostate adenocarcinoma cell line LNCaP.FGC","volume":"15","author":"Gunnersen","year":"1995","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116634_b0175","doi-asserted-by":"crossref","unstructured":"Tevz, G., McGrath, S., Demeter, R., Magrini, V., Jeet, V., Rockstroh, A. et al. (2016) Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer Mol Cell Endocrinol 420, 159-168 10.1016\/j.mce.2015.10.011.","DOI":"10.1016\/j.mce.2015.10.011"},{"key":"10.1016\/j.bcp.2024.116634_b0180","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1021\/acs.jproteome.4c00027","article-title":"Identification and Quantification of Human Relaxin Proteins by Immunoaffinity-Mass Spectrometry","volume":"23","author":"Rais","year":"2024","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bcp.2024.116634_b0185","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/pros.21148","article-title":"Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer","volume":"70","author":"Thompson","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.bcp.2024.116634_b0190","doi-asserted-by":"crossref","unstructured":"Vinall, R., Mahaffey, C., Davis, R., Luo, Z., Gandour-Edwards, R., Ghosh, P. et al. (2011) Dual Blockade of PKA and NF\u2013\u03baB Inhibits H2 Relaxin-Mediated Castrate-Resistant Growth of Prostate Cancer Sublines and Induces Apoptosis Hormones and Cancer 2, 224-238 10.1007\/s12672-011-0076-4.","DOI":"10.1007\/s12672-011-0076-4"},{"key":"10.1016\/j.bcp.2024.116634_b0195","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1158\/1078-0432.CCR-06-2492","article-title":"Relaxin promotes prostate cancer progression","volume":"13","author":"Feng","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2024.116634_b0200","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1073\/pnas.0530278100","article-title":"Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum","volume":"100","author":"Welsh","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2024.116634_b0205","doi-asserted-by":"crossref","unstructured":"Munkley, J., Maia, T., Ibarluzea, N., Livermore, K., Vodak, D., Ehrmann, I. et al. (2018) Androgen-dependent alternative mRNA isoform expression in prostate cancer cells [version 1; peer review: 3 approved] F1000Research 7, 10.12688\/f1000research.15604.1.","DOI":"10.12688\/f1000research.15604.1"},{"key":"10.1016\/j.bcp.2024.116634_b0210","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1196\/annals.1282.069","article-title":"Human medullary thyroid carcinoma: a source and potential target for relaxin-like hormones","volume":"1041","author":"Klonisch","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bcp.2024.116634_b0215","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2353\/ajpath.2006.050876","article-title":"Relaxin enhances the oncogenic potential of human thyroid carcinoma cells","volume":"169","author":"Hombach-Klonisch","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bcp.2024.116634_b0220","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1158\/1541-7786.MCR-10-0411","article-title":"Relaxin enhances the collagenolytic activity and in vitro invasiveness by upregulating matrix metalloproteinases in human thyroid carcinoma cells","volume":"9","author":"Bialek","year":"2011","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bcp.2024.116634_b0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00432-020-03401-9","article-title":"BRAFV600E, hypothyroidism, and human relaxin in thyroid carcinogenesis","volume":"147","author":"Hernandez","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bcp.2024.116634_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116323","article-title":"Relaxin-2 is a novel biomarker for differentiated thyroid carcinoma in humans","volume":"225","author":"Kotwal","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116634_b0235","doi-asserted-by":"crossref","unstructured":"Radestock, Y., Willing, C., Kehlen, A., Hoang-Vu, C., andHombach-Klonisch, S. (2010) Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts Mol Cancer Res 8, 494-506 10.1158\/1541-7786.MCR-09-0307.","DOI":"10.1158\/1541-7786.MCR-09-0307"},{"key":"10.1016\/j.bcp.2024.116634_b0240","first-page":"1102","article-title":"RNAi-mediated knockdown of relaxin decreases in vitro proliferation and invasiveness of osteosarcoma MG-63 cells by inhibition of MMP-9","volume":"17","author":"Ma","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.bcp.2024.116634_b0245","doi-asserted-by":"crossref","unstructured":"Ma, J., Niu, M., Yang, W., Zang, L., andXi, Y. (2013) Role of relaxin-2 in human primary osteosarcoma Cancer Cell Int 13, 59 10.1186\/1475-2867-13-59.","DOI":"10.1186\/1475-2867-13-59"},{"key":"10.1016\/j.bcp.2024.116634_b0250","first-page":"2828","article-title":"Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma","volume":"18","author":"Huang","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.bcp.2024.116634_b0255","doi-asserted-by":"crossref","unstructured":"Ma, J., Huang, H., Han, Z., Zhu, C., andYue, B. (2015) RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance BioMed Research International 2015, 147468 https:\/\/doi.org\/10.1155\/2015\/147468.","DOI":"10.1155\/2015\/147468"},{"key":"10.1016\/j.bcp.2024.116634_b0260","doi-asserted-by":"crossref","unstructured":"Marioni, G., Zanoletti, E., Lovato, A., Franchella, S., Giacomelli, L., Gianatti, A. et al. (2015) Relaxin-2 expression in temporal bone carcinoma Eur Arch Otorhinolaryngol 272, 3225-3232 10.1007\/s00405-014-3383-x.","DOI":"10.1007\/s00405-014-3383-x"},{"key":"10.1016\/j.bcp.2024.116634_b0265","first-page":"e122","article-title":"Heterozygous deletion at the RLN1 locus in a family with testicular germ cell cancer identified by integrating copy number variation data with phenome and interactome information International","volume":"34","author":"Edsg\u00e4rd","year":"2011","journal-title":"J. Androl."},{"key":"10.1016\/j.bcp.2024.116634_b0270","unstructured":"H.Z. Pan A.B. Dong L. Wang S.S. Tan Q. Yang X.Y. Tong et al. Significance of relaxin-2 expression in hepatocellular carcinoma: relation with clinicopathological parameters Eur Rev Med Pharmacol Sci 17, 1095-1101 2013 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23661524."},{"key":"10.1016\/j.bcp.2024.116634_b0275","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5301\/jbm.5000219","article-title":"Relaxin-2 Expression in Oral Squamous Cell Carcinoma","volume":"31","author":"Marioni","year":"2016","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.bcp.2024.116634_b0280","doi-asserted-by":"crossref","unstructured":"J. Bialek M. Piwonka F. Kawan P. Fornara andTheil, G. Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer Life Basel) 11 2021 DOI: 10.3390\/life11080731.","DOI":"10.3390\/life11080731"},{"key":"10.1016\/j.bcp.2024.116634_b0285","doi-asserted-by":"crossref","unstructured":"Stewart, D. R. (2019) Commercial immunoassays for human relaxin-2 Mol Cell Endocrinol 487, 94-97 10.1016\/j.mce.2019.01.004.","DOI":"10.1016\/j.mce.2019.01.004"},{"key":"10.1016\/j.bcp.2024.116634_b0290","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/B:BREA.0000041622.30169.16","article-title":"Elevated Concentrations of Serum Relaxin are Associated with Metastatic Disease in Breast Cancer Patients","volume":"87","author":"Binder","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bcp.2024.116634_b0295","unstructured":"Sherwood, O. D. (1994) Relaxin In The physiology of reproduction, 2 Ed. Knobil E, Neill JD, eds. Raven Press, New York 861-1009."},{"key":"10.1016\/j.bcp.2024.116634_b0300","first-page":"2412","article-title":"Elevated serum levels of human relaxin-2 in patients with esophageal squamous cell carcinoma World","volume":"19","author":"Ren","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.bcp.2024.116634_b0305","doi-asserted-by":"crossref","unstructured":"Xu, Y., Yu, Q., andLiu, Y. (2018) Serum relaxin-2 as a novel biomarker for prostate cancer Br J Biomed Sci 75, 145-148 10.1080\/09674845.2018.1424499.","DOI":"10.1080\/09674845.2018.1424499"},{"key":"10.1016\/j.bcp.2024.116634_b0310","first-page":"81","article-title":"andLv, Y","volume":"21","author":"Guo","year":"2017","journal-title":"Serum Relaxin as a Diagnostic and Prognostic Marker in Patients with Epithelial Ovarian Cancer Cancer Biomark"},{"key":"10.1016\/j.bcp.2024.116634_b0315","first-page":"99","article-title":"andPaschopoulos, M","volume":"260","author":"Gkrozou","year":"2021","journal-title":"Relaxin as a Potential Diagnostic Biomarker for Ovarian Cancer- A Prospective Study Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bcp.2024.116634_b0320","doi-asserted-by":"crossref","unstructured":"Ivell, R., Balvers, M., Pohnke, Y., Telgmann, R., Bartsch, O., Milde-Langosch, K. et al. (2003) Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates Reprod Biol Endocrinol 1, 114 10.1186\/1477-7827-1-114.","DOI":"10.1186\/1477-7827-1-114"},{"key":"10.1016\/j.bcp.2024.116634_b0325","doi-asserted-by":"crossref","unstructured":"Radestock, Y., Hoang-Vu, C., andHombach-Klonisch, S. (2008) Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells Breast Cancer Res 10, R71 10.1186\/bcr2136.","DOI":"10.1186\/bcr2136"},{"key":"10.1016\/j.bcp.2024.116634_b0330","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10585-013-9609-2","article-title":"Relaxins enhance growth of spontaneous murine breast cancers as well as metastatic colonization of the brain","volume":"31","author":"Binder","year":"2014","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.bcp.2024.116634_b0335","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-18-2953","article-title":"Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies","volume":"25","author":"Landa","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2024.116634_b0340","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1749-6632.2008.03803.x","article-title":"Relaxin Signaling in Uterine Fibroids","volume":"1160","author":"Li","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcp.2024.116634_b0345","doi-asserted-by":"crossref","unstructured":"Domi\u0144ska, K., Urbanek, K. A., Kowalska, K., Habrowska-G\u00f3rczy\u0144ska, D. E., Kozie\u0142, M. J., Och\u0119dalski, T. et al. (2024) The consequences of manipulating relaxin family peptide receptor 1 (RXFP1) level in ovarian cancer cells Reprod Biol 24, 100864 10.1016\/j.repbio.2024.100864.","DOI":"10.1016\/j.repbio.2024.100864"},{"key":"10.1016\/j.bcp.2024.116634_b0350","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/path.4257","article-title":"C1q-tumour necrosis factor-related protein 8 (CTRP8) is a novel interaction partner of relaxin receptor RXFP1 in human brain cancer cells","volume":"231","author":"Glogowska","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.bcp.2024.116634_b0355","first-page":"2993","volume":"10","author":"Hu","year":"2019","journal-title":"Relaxin Gene Delivery Mitigates Liver Metastasis and Synergizes with Check Point Therapy Nat Commun"},{"key":"10.1016\/j.bcp.2024.116634_b0360","doi-asserted-by":"crossref","first-page":"eabb6596","DOI":"10.1126\/sciadv.abb6596","article-title":"Relaxin gene delivery modulates macrophages to resolve cancer fibrosis and synergizes with immune checkpoint blockade therapy","volume":"7","author":"Zhou","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bcp.2024.116634_b0365","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF03348479","article-title":"Effects of relaxin on the mouse mammary gland. I","volume":"8","author":"Bani","year":"1985","journal-title":"The Myoepithelial Cells J Endocrinol Invest"},{"key":"10.1016\/j.bcp.2024.116634_b0370","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03348086","article-title":"The effects of relaxin on the mouse mammary gland","volume":"9","author":"Bani","year":"1986","journal-title":"II. the Epithelium J Endocrinol Invest"},{"key":"10.1016\/j.bcp.2024.116634_b0375","first-page":"639","article-title":"Relaxin influences the growth of MCF-7 breast cancer cells","volume":"70","author":"Bigazzi","year":"1992","journal-title":"Mitogenic and Antimitogenic Action Depends on Peptide Concentration Cancer"},{"key":"10.1016\/j.bcp.2024.116634_b0380","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijc.2910570123","article-title":"Relaxin influences growth, differentiation and cell-cell adhesion of human breast-cancer cells in culture","volume":"57","author":"Sacchi","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2024.116634_b0385","doi-asserted-by":"crossref","unstructured":"Sarwar, M., Samuel, C. S., Bathgate, R. A., Stewart, D. R., andSummers, R. J. (2015) Serelaxin-mediated signal transduction in human vascular cells: bell-shaped concentration-response curves reflect differential coupling to G proteins Br J Pharmacol 172, 1005-1019 10.1111\/bph.12964.","DOI":"10.1111\/bph.12964"},{"key":"10.1016\/j.bcp.2024.116634_b0390","first-page":"5272","article-title":"Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells","volume":"55","author":"Bani","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2024.116634_b0395","first-page":"789","article-title":"andEinspanier, A","volume":"8","author":"Binder","year":"2002","journal-title":"Relaxin Enhances in-Vitro Invasiveness of Breast Cancer Cell Lines by up-Regulation of Matrix Metalloproteases Mol Human Reprod"},{"key":"10.1016\/j.bcp.2024.116634_b0400","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm879","article-title":"Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation","volume":"9","author":"Brown","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2024.116634_b0405","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nmeth.1295","article-title":"In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts","volume":"6","author":"Perentes","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bcp.2024.116634_b0410","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1210\/en.2003-0248","article-title":"Adenovirus-Mediated Expression of Human Prorelaxin Promotes the Invasive Potential of Canine Mammary Cancer Cells","volume":"144","author":"Silvertown","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116634_b0415","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ijc.21288","article-title":"H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis","volume":"118","author":"Silvertown","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2024.116634_b0420","first-page":"609","article-title":"Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4\/MMPs signaling","volume":"17","author":"Cao","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.bcp.2024.116634_b0425","first-page":"2566","article-title":"andYuan, F","volume":"7","author":"Henshaw","year":"2008","journal-title":"Relaxin Treatment of Solid Tumors: Effects on Electric Field-Mediated Gene Delivery Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2024.116634_b0430","doi-asserted-by":"crossref","unstructured":"Suzuki, K., Nakabayashi, K., Yamada, A. Y., Lodhi, R. S., Hazama, R., Ebina, Y. et al. (2012) Recombinant H2 relaxin inhibits apoptosis and induces cell proliferation in cultured leiomyoma cells without affecting those in cultured normal myometrial cells Fertil Steril 97, 734-741 10.1016\/j.fertnstert.2011.12.011.","DOI":"10.1016\/j.fertnstert.2011.12.011"},{"key":"10.1016\/j.bcp.2024.116634_b0435","doi-asserted-by":"crossref","unstructured":"Liu, T., Wang, X., Zhai, J., Wang, Q., andZhang, B. (2021) Long Noncoding RNA UCA1 Facilitates Endometrial Cancer Development by Regulating KLF5 and RXFP1 Gene Expressions Cancer Biother Radiopharm 36, 521-533 10.1089\/cbr.2019.3278.","DOI":"10.1089\/cbr.2019.3278"},{"key":"10.1016\/j.bcp.2024.116634_b0440","doi-asserted-by":"crossref","unstructured":"RHO, Y. S., andMIN, G. (2005) Relaxin Does Not Influence the Growth of Human Cervical Adenocarcinoma (HeLa) Cells in Culture Annals of the New York Academy of Sciences 1041, 470-480 https:\/\/doi.org\/10.1196\/annals.1282.071.","DOI":"10.1196\/annals.1282.071"},{"key":"10.1016\/j.bcp.2024.116634_b0445","doi-asserted-by":"crossref","unstructured":"Vinall, R. L., Tepper, C. G., Shi, X. B., Xue, L. A., Gandour-Edwards, R., andde Vere White, R. W. (2006) The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7 Oncogene 25, 2082-2093 10.1038\/sj.onc.1209246.","DOI":"10.1038\/sj.onc.1209246"},{"key":"10.1016\/j.bcp.2024.116634_b0450","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/sj.onc.1210671","article-title":"Inappropriate activation of androgen receptor by relaxin via [beta]-catenin pathway","volume":"27","author":"Liu","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2024.116634_b0455","doi-asserted-by":"crossref","unstructured":"Domi\u0144ska, K., Och\u0119dalski, T., Kowalska, K., Matysiak\u2011Burzy\u0144ska, Z. E., P\u0142uciennik, E., andPiastowska-Ciesielska, A. W. (2016) Interaction between angiotensin II and relaxin 2 in the progress of growth and spread of prostate cancer cells Int J Oncol 48, 2619-2628 10.3892\/ijo.2016.3458.","DOI":"10.3892\/ijo.2016.3458"},{"key":"10.1016\/j.bcp.2024.116634_b0460","doi-asserted-by":"crossref","unstructured":"Domi\u0144ska, K., Och\u0119dalski, T., Kowalska, K., Matysiak-Burzy\u0144ska, Z. E., P\u0142uciennik, E., andPiastowska-Ciesielska, A. W. (2016) A common effect of angiotensin II and relaxin 2 on the PNT1A normal prostate epithelial cell line J Physiol Biochem 72, 381-392 10.1007\/s13105-016-0489-1.","DOI":"10.1007\/s13105-016-0489-1"},{"key":"10.1016\/j.bcp.2024.116634_b0465","doi-asserted-by":"crossref","unstructured":"Domi\u0144ska, K., Kowalska, K., Matysiak, Z. E., P\u0142uciennik, E., Och\u0119dalski, T., andPiastowska\u2011Ciesielska, A. W. (2017) Regulation of mRNA gene expression of members of the NF-\u03baB transcription factor gene family by angiotensin II and relaxin 2 in normal and cancer prostate cell lines Mol Med Rep 15, 4352-4359 10.3892\/mmr.2017.6514.","DOI":"10.3892\/mmr.2017.6514"},{"key":"10.1016\/j.bcp.2024.116634_b0470","doi-asserted-by":"crossref","unstructured":"Feng, S., Agoulnik, I. U., Truong, A., Li, Z., Creighton, C. J., Kaftanovskaya, E. M. et al. (2010) Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis Endocr Relat Cancer 17, 1021-1033 10.1677\/erc-10-0073.","DOI":"10.1677\/ERC-10-0073"},{"key":"10.1016\/j.bcp.2024.116634_b0475","doi-asserted-by":"crossref","unstructured":"Feng, S., andAgoulnik, A. I. (2011) Expression of LDL-A module of relaxin receptor in prostate cancer cells inhibits tumorigenesis Int J Oncol 39, 1559-1565 10.3892\/ijo.2011.1159.","DOI":"10.3892\/ijo.2011.1159"},{"key":"10.1016\/j.bcp.2024.116634_b0480","doi-asserted-by":"crossref","unstructured":"Silvertown, J. D., Symes, J. C., Neschadim, A., Nonaka, T., Kao, J. C. H., Summerlee, A. J. S. et al. (2007) Analog of H2 relaxin exhibits antagonistic properties and impairs prostate tumor growth FASEB J 21, 754-765 10.1096\/fj.06-6847com.","DOI":"10.1096\/fj.06-6847com"},{"key":"10.1016\/j.bcp.2024.116634_b0485","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/ijc.29079","article-title":"Targeting the relaxin hormonal pathway in prostate cancer","volume":"137","author":"Neschadim","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2024.116634_b0490","first-page":"1030","article-title":"RLN2 regulates in vitro invasion and viability of osteosarcoma MG-63 cells via S100A4\/MMP-9 signal","volume":"19","author":"Ren","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.bcp.2024.116634_b0495","doi-asserted-by":"crossref","unstructured":"Xu, J., Wan, S., Chen, W., Zhang, Y., andJi, Z. (2022) Relaxin inhibits (177)Lu-EDTMP associated cell death in osteosarcoma cells through notch-1 pathway Acta Pharm 72, 575-585 10.2478\/acph-2022-0032.","DOI":"10.2478\/acph-2022-0032"},{"key":"10.1016\/j.bcp.2024.116634_b0500","doi-asserted-by":"crossref","unstructured":"N. Saeki A. Saito Y. Sugaya M. Amemiya H. Ono R. Komatsuzaki et al. Chromatin Immunoprecipitation and DNA Sequencing Identified a LIMS1\/ILK Pathway Regulated by LMO1 in Neuroblastoma Cancer Genomics - Proteomics 15, 165-174 2018 https:\/\/cgp.iiarjournals.org\/content\/cgp\/15\/3\/165.full.pdf.","DOI":"10.21873\/cgp.20074"},{"key":"10.1016\/j.bcp.2024.116634_b0505","doi-asserted-by":"crossref","unstructured":"D.F. Mardhian G. Storm R. Bansal andPrakash J. Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo J Control Release 290 2018 1 10 10.1016\/j.jconrel.2018.09.031.","DOI":"10.1016\/j.jconrel.2018.09.031"},{"key":"10.1016\/j.bcp.2024.116634_b0510","doi-asserted-by":"crossref","unstructured":"Zhou, X., Liu, Y., Hu, M., Wang, M., Liu, X., andHuang, L. (2021) Relaxin gene delivery modulates macrophages to resolve cancer fibrosis and synergizes with immune checkpoint blockade therapy Sci Adv 7, 10.1126\/sciadv.abb6596.","DOI":"10.1126\/sciadv.abb6596"},{"key":"10.1016\/j.bcp.2024.116634_b0515","unstructured":"Wang, L., Zhou, Y., Lin, H., andHou, K. (2023) Protective Effects of Relaxin 2 (RLXH2) against Hypoxia-Induced Oxidative Damage and Cell Death via Activation of The Nrf2\/HO-1 Signalling Pathway in Gastric Cancer Cells Cell J 25, 625-632 10.22074\/cellj.2023.2000342.1287."},{"key":"10.1016\/j.bcp.2024.116634_b0520","doi-asserted-by":"crossref","unstructured":"Xiong, F., Cao, Y., Guo, X., Zhang, H., Wang, J., Xiong, B. et al. (2020) Improved ADM Penetration Distance and Therapeutic Efficiency in a Rabbit VX2 Liver Cancer Model by Relaxin Infusion Combined with Transcatheter Chemoembolization Through Hepatic Artery Cancer Manag Res 12, 3379-3388 10.2147\/cmar.S223993.","DOI":"10.2147\/CMAR.S223993"},{"key":"10.1016\/j.bcp.2024.116634_b0525","doi-asserted-by":"crossref","unstructured":"Wang, F., Zhu, L., Xiong, F., Chai, B., Wang, J., Zhou, G. et al. (2024) Relaxin combined with transarterial chemoembolization achieved synergistic effects and inhibited liver cancer metastasis in a rabbit VX2 model J Cancer Res Clin Oncol 150, 333 10.1007\/s00432-024-05864-6.","DOI":"10.1007\/s00432-024-05864-6"},{"key":"10.1016\/j.bcp.2024.116634_b0530","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Guo, J., Gong, C., Wu, S., andSun, Y. (2024) KIAA1429-mediated RXFP1 attenuates non-small cell lung cancer tumorigenesis via N6-methyladenosine modification Cancer Biomark 10.3233\/cbm-230188.","DOI":"10.3233\/CBM-230188"},{"key":"10.1016\/j.bcp.2024.116634_b0535","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1074\/jbc.M506665200","article-title":"Relaxin Stimulates Leukocyte Adhesion and Migration through a Relaxin Receptor LGR7-dependent Mechanism","volume":"281","author":"Figueiredo","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2024.116634_b0540","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1749-6632.2009.03843.x","article-title":"Relaxin Promotes Clustering, Migration, and Activation States of Mononuclear Myelocytic Cells","volume":"1160","author":"Figueiredo","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcp.2024.116634_b0545","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1038\/s41467-019-10893-8","article-title":"Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy","volume":"10","author":"Hu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2024.116634_b0550","article-title":"Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy Asian","volume":"18","author":"Zhang","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bcp.2024.116634_b0555","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djj397","article-title":"Relaxin Expression From Tumor-Targeting Adenoviruses and Its Intratumoral Spread","volume":"98","author":"Kim","year":"2006","journal-title":"Apoptosis Induction, and Efficacy J Natl Cancer Inst"},{"key":"10.1016\/j.bcp.2024.116634_b0560","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1158\/0008-5472.CAN-06-4260","article-title":"Relaxin-Expressing, Fiber Chimeric Oncolytic Adenovirus Prolongs Survival of Tumor-Bearing Mice","volume":"67","author":"Ganesh","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2024.116634_b0565","doi-asserted-by":"crossref","unstructured":"Lavilla-Alonso, S., Bauer, M. M. T., Abo-Ramadan, U., Ristim\u00e4ki, A., Halavaara, J., Desmond, R. A. et al. (2012) Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases development Cancer Gene Ther 19, 126-134 10.1038\/cgt.2011.76.","DOI":"10.1038\/cgt.2011.76"},{"key":"10.1016\/j.bcp.2024.116634_b0570","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3727\/096504013X13657689383139","article-title":"Therapeutic effect of oncolytic adenovirus expressing relaxin in radioresistant oral squamous cell carcinoma","volume":"20","author":"Lee","year":"2013","journal-title":"Oncol Res"},{"key":"10.1016\/j.bcp.2024.116634_b0575","first-page":"515","volume":"32","author":"Kang","year":"2014","journal-title":"Down-Regulation of Collagen Synthesis and Matrix Metalloproteinase Expression in Myofibroblasts from Dupuytren Nodule Using Adenovirus-Mediated Relaxin Gene Therapy J Orth Res"},{"key":"10.1016\/j.bcp.2024.116634_b0580","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2017.03.009","article-title":"Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer","volume":"396","author":"Jung","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2024.116634_b0585","first-page":"75","volume":"305","author":"Na","year":"2019","journal-title":"Systemic Administration of Human Mesenchymal Stromal Cells Infected with Polymer-Coated Oncolytic Adenovirus Induces Efficient Pancreatic Tumor Homing and Infiltration J Controlled Release"},{"key":"10.1016\/j.bcp.2024.116634_b0590","doi-asserted-by":"crossref","unstructured":"Jung, B. K., Ko, H. Y., Kang, H., Hong, J., Ahn, H. M., Na, Y. et al. (2020) Relaxin-expressing oncolytic adenovirus induces remodeling of physical and immunological aspects of cold tumor to potentiate PD-1 blockade J Immunother Cancer 8, 10.1136\/jitc-2020-000763.","DOI":"10.1136\/jitc-2020-000763"},{"key":"10.1016\/j.bcp.2024.116634_b0595","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1182\/blood-2008-10-187237","article-title":"Toward a stem cell gene therapy for breast cancer","volume":"113","author":"Li","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2024.116634_b0600","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/mt.2010.256","article-title":"Controlled extracellular matrix degradation in breast cancer tumors improves therapy by trastuzumab","volume":"19","author":"Beyer","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.bcp.2024.116634_b0605","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jconrel.2019.12.053","article-title":"Relaxin-FOLFOX-IL-12 triple combination therapy engages memory response and achieves long-term survival in colorectal cancer liver metastasis","volume":"319","author":"Hu","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.bcp.2024.116634_b0610","first-page":"104","volume":"5","author":"Klonisch","year":"1999","journal-title":"Expression of Relaxin-like Factor Is down-Regulated in Human Testicular Leydig Cell Neoplasia Mol Human Reprod"},{"key":"10.1016\/j.bcp.2024.116634_b0615","first-page":"546","article-title":"andSteger, K","volume":"72","author":"Klonisch","year":"1999","journal-title":"Relaxin-like Factor Expression in a Human Ovarian Sertoli-Leydig Cell Tumor Fertility and Sterility"},{"key":"10.1016\/j.bcp.2024.116634_b0620","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.urolonc.2008.10.015","article-title":"The novel hormone INSL3 is expressed in human testicular Leydig cell tumors: A clinical and immunohistochemical study","volume":"29","author":"Rossato","year":"2011","journal-title":"Urologic Oncology: Seminars and Original Investigations"},{"key":"10.1016\/j.bcp.2024.116634_b0625","doi-asserted-by":"crossref","unstructured":"Lakis, N. S., Lombardo, K. A., Mangray, S., Netto, G. J., Salles, D., andMatoso, A. (2019) INSL3 Expression in Leydig Cell Hyperplasia and Leydig Cell Tumors Appl Immunohistochem Mol Morphol 27, 203-209 10.1097\/pai.0000000000000567.","DOI":"10.1097\/PAI.0000000000000567"},{"key":"10.1016\/j.bcp.2024.116634_b0630","doi-asserted-by":"crossref","unstructured":"T. Klonisch H. Muller-Huesmann M. Riedel A. Kehlen J. Bialek Y. Radestock et al. INSL3 in the benign hyperplastic and neoplastic human prostate gland Int J Oncol 27, 307-315 2005 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16010410.","DOI":"10.3892\/ijo.27.2.307"},{"key":"10.1016\/j.bcp.2024.116634_b0635","doi-asserted-by":"crossref","unstructured":"A.-M. Bamberger R. Ivell M. Balvers B. Kelp C.M. Bamberger L. Riethdorf et al. Relaxin-Like Factor (RLF): A New Specific Marker for Leydig Cells in the Ovary Int J Gynecol Pathol 18, 163-168 1999 https:\/\/journals.lww.com\/intjgynpathology\/fulltext\/1999\/04000\/relaxin_like_factor__rlf___a_new_specific_marker.11.aspx.","DOI":"10.1097\/00004347-199904000-00011"},{"key":"10.1016\/j.bcp.2024.116634_b0640","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/1541-7786.MCR-22-0623","article-title":"Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors","volume":"21","author":"Khlebus","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcp.2024.116634_b0645","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/172460080702200210","article-title":"Elevated Plasma Levels of the Novel Hormone INSL3 in a Woman with Metastatic Ovarian Cancer","volume":"22","author":"Rossato","year":"2007","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.bcp.2024.116634_b0650","doi-asserted-by":"crossref","unstructured":"Hombach-Klonisch, S., Buchmann, J., Sarun, S., Fischer, B., andKlonisch, T. (2000) Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland Cancer 89, 2161-2168 https:\/\/doi.org\/10.1002\/1097-0142(20001201)89:11<2161::AID-CNCR3>3.0.CO;2-K.","DOI":"10.1002\/1097-0142(20001201)89:11<2161::AID-CNCR3>3.0.CO;2-K"},{"key":"10.1016\/j.bcp.2024.116634_b0655","doi-asserted-by":"crossref","unstructured":"S. Hombach-Klonisch C. Hoang-Vu A. Kehlen R. Hinze H.J. Holzhausen E. Weber et al. INSL-3 is expressed in human hyperplastic and neoplastic thyrocytes Int J Oncol 22, 993-1001 2003 http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12684664.","DOI":"10.3892\/ijo.22.5.993"},{"key":"10.1016\/j.bcp.2024.116634_b0660","doi-asserted-by":"crossref","unstructured":"Bialek, J., Hombach-Klonisch, S., Fiebig, B., Weber, E., Hoang-Vu, C., andKlonisch, T. (2009) Lysosomal Acid Hydrolases of the Cathepsin Family Are Novel Targets of INSL3 in Human Thyroid Carcinoma Cells Annals of the New York Academy of Sciences 1160, 361-366 https:\/\/doi.org\/10.1111\/j.1749-6632.2009.03832.x.","DOI":"10.1111\/j.1749-6632.2009.03832.x"},{"key":"10.1016\/j.bcp.2024.116634_b0665","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ijc.25068","article-title":"INSL3 has tumor-promoting activity in thyroid cancer","volume":"127","author":"Hombach-Klonisch","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2024.116634_b0670","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0167-0115(02)00304-X","article-title":"Production of recombinant human relaxin 3 in AtT20 cells","volume":"113","author":"Kizawa","year":"2003","journal-title":"Regul. Pept."},{"key":"10.1016\/j.bcp.2024.116634_b0675","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jnr.21895","article-title":"Regulation of relaxin 3 gene expression via cAMP-PKA in a neuroblastoma cell line","volume":"87","author":"Tanaka","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bcp.2024.116634_b0680","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2010.02.006","article-title":"Promoter hypermethylation of CIDEA, HAAO and RXFP3 associated with microsatellite instability in endometrial carcinomas","volume":"117","author":"Huang","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bcp.2024.116634_b0685","first-page":"e91905","volume":"9","author":"Hansel","year":"2014","journal-title":"A Promising DNA Methylation Signature for the Triage of High-Risk Human Papillomavirus DNA-Positive Women PLOS ONE"},{"key":"10.1016\/j.bcp.2024.116634_b0690","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13148-017-0419-2","article-title":"Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women Clin","volume":"9","author":"Schmitz","year":"2017","journal-title":"Epigenetics"},{"key":"10.1016\/j.bcp.2024.116634_b0695","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1186\/s12885-018-5125-8","article-title":"Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages","volume":"18","author":"Schmitz","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2024.116634_b0700","first-page":"22947","volume":"NY) 13","author":"Wu","year":"2021","journal-title":"A Novel Prognostic Signature Based on Immune-Related Genes of Diffuse Large B-Cell Lymphoma Aging (albany"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224006348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224006348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:31:29Z","timestamp":1788982289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224006348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":140,"alternative-id":["S0006295224006348"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116634","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Relaxin Signaling in Cancer: A Review","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116634","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116634"}}